BRIEF-Rigel Pharmaceuticals q2 loss per share $0.15
August 02, 2016 at 17:00 PM EDT
* Expects cash, cash equivalents and short-term investments as Of June 30 to be sufficient to fund operations into q3 of 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.